intending resourceful laboratories or Diagnostic centres for empanelment for laboratory investigations not available inhouse in GMCH, Guwahati

Serrum Carbamazepine

Serrum Valproate

Serrum Lithium

Serrum Clozapine

Serrum Lithium, Valporate, CPK

Urine Toxicology screening

Urine for Porphobilinogen

Plasma aldosterone concentration (PAC)/ Plasma renin activity (PRA) : Chemiluminiscence immunoassay

24 hour urine metanephrine and normetanephrine : ELISA/HPLC

IGFBP3 : Immunochemiluminometric assay (ICMA)

IgA anti TTG, Total IgA (serum) : ELISA

Urine potassium, urine phosphate, urine creatinine : Spectrophotometry

Serum FGF23 : ELISA

Serum calcitriol : Immunochemiluminometric assay (ICMA)

Plasma ACTH : Chemiluminiscence

Serum 17 OH P : Chemiluminiscence

Serum beta hydroxy butyrate (BOHB) : Chemiluminiscence

BMD DEXA scan : Hypercalcemia, osteoporosis

: MG060B-Hypocalcemia

PET SCAN : MG098A- Pet Scan

Mucopolysaccharidosis screen, urine : Toluidine blue spot test

Next generation sequencing whole genome sequencing : MP036A- Inborn errors of metabolism

Whole body iodine scan : MR015- Iodine treatment 3mCi

Tc 99m scan thyroid : hyperparathyroidism

Serum GAD65 antibody, IA- 2 antibody, IAA antibody : ELISA

Tc99m SESTAMIBI scan : Nuclear scan

Serum DHEAS :

Serum androstenedione serum DHT : Chemiluminiscence/ELISA

Whole blood karyotype : Genetic analysis

Thyroglobulin, anti TG antibody : Electrochemiluminiscence assay

Calcitonin : Chemiluminiscence

Autoimmune encephalitis panel-2 (Includese NMDA, AMPA) (GluR1 + GluR2), GABA B receptor, VGKC (LGI1, CASPR2), DPPX by IFA) : IFA

Anti NMDA receptor encephalitis IgG antibodies : Immuno Fluores- Cent Assay

Anti VGKC igG Ab : Immuno Fluores- Cent Assay

Paraneoplastic Disorder Profile : Immunoblot

Anti MAG (Myelin Associated Glycoprotein) Ab : Indirect Immunofluorescence

NSE (neuron Specific Enolase) : ElectroChemiluminesce

Anti-Aquaporin-4/NMO Antibodies (Neuromyelitis Optica) : Immuno Fluores- Cent Assay

NMO + MOG Antibodies : Immuno Fluores- Cent Assay

Oligoclonal Band Serum & CSF : Immunofixation with Isoelectric Focusing

IGG INDEX, SERUM and CSF : Immunoturbidimetry

Multiple Sclerosis Profile (CSF IgG Index, Serum and CSF & Oligoclonal Bands, CSF) : Immunoturbidimetry/ISO Electric focusing immunofixation

Acetycholine Receptor Antibodies : EIA

Anti Musk Antibodies Serum : Radio Immunoassay

Neuromuscular Disorders MTDNA Mutation Panel (MELAS + MERRF) : PCR Sequencing

SCA Panel (SCA 1, 2, 3, 6, 12) : PCR- Fragment Analysis

SCA 1 (Spinal Cerebral Ataxia Type-1) : PCR- Fragment Analysis

SCA 2 (Spinal Cerebral Ataxia Type-2) : PCR- Fragment Analysis

SCA 3 (Spinal Cerebral Ataxia Type-3) : PCR- Fragment Analysis

SCA 6 (Spinal Cerebral Ataxia Type-6) : PCR- Fragment Analysis

SCA 7 (Spinal Cerebral Ataxia Type-7) : PCR- Fragment Analysis

SCA 10 (Spinal Cerebral Ataxia Type-10) : PCR- Fragment Analysis

SCA 12 (Spinal Cerebral Ataxia Type-12) : PCR- Fragment Analysis

SCA 17 (Spinal Cerebral Ataxia Type-17) : PCR- Fragment Analysis

DRPLA Gene Analysis : PCR- Fragment Analysis

Cytogenetics: Fragile- X, Chromo Analysis : Karyotype Cell Culture

Digeorge Syndrome, 22Q11.2 Deletion : Fish

Freidreichs Ataxia Mutation Analysis : PCR - Fragment Analysis

Miller Diekker Syndrome : Fish

RETT Syndrome DNA Sequencing (MECP2 Mutation) Methyl CPG Binding Protein 2 : DNA Sequencing

Angelmans Syndrome MS Pcr : Methylation Spe-cific- PCR

Prader- Willi Syndrome MS Pcr : Methylation Spe-cific- PCR

Huntington Disease Molecular Anlysis : PCR - Fragment Analysis

Myotonic Dystrophy Pndt : Fragment Analysis

Myotonic Dystrophy : Fragment Analysis

Duchenne/Becker Muscular Dystrophy (DMD/BMD) : Multiplex Ligation Dependent Probe Amplification

Duchenne Muscular Dystrophy (DMD) (18 Exons) : Multiplex PCR

Spinal Muscular Atrophy Microdeletion PCR PNDT : PCR Sequencing

SMA Carrier Detection : MLPA- Fragment Analysis

Spinal Muscular Atrophy Microdeletion PCR : PCR Sequencing

Universal Genetic test : Microarray

Clinical Exome Analysis : Next Generation Sequencing

Clinical Exome & Mitochondrial DNA Anslysis Panel : Next Generation Sequencing

Fragile x (FMR 1) Mutation Screen : Triplet Primed PCR Fragment Analysis

CAH (Congenital Adrenal Hyperplasia) full gene sequence analysis : Sanger Sequencing

Early infatile epileptic encephalopathy gene panel : NGS

Dystonia Gene Panel : NGS

Binign Infantile Epilepsy Gene Panel : NGS

Neuronal Ceroid Lipofuscinosis Gene Panel : NGS

Arthrogryposis and Congenital Myasthenic Syndrome gene Panle : NGS

Spinal Muscular Atrophy Gene Panel : NGS

Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel : NGS

Microcephaly Gene Panel : NGS

Retinal Degeneration Gene Panel : NGS

Ataxia Gene Panel : NGS

CXCR4 Gene Mutation Analysis : Sanger Sequencing

CAH deletion & duplication detection : MLPA

B1 gene deletion & duplication detection *Retinoblastoma) : MLPA

Glycogen Storage Disorder : NGS

Metabolic Disorder Gene : NGS

Autism Gene panel : NGS

Hereditary Spastic Paraplegia gene Panel : NGS

Lysosomal Storage Disorder Gene Apnel : NGS

RETT Syndrome deletion & dulication detection : MLPA

Thrombocheck Total Protein C Activity, Free Protein S Antigen Levels, Antithrombin Activity (Chromo-Genic), Lupus Anticoagulant (Both APTT and RVVT absed), Anticardiolipin Antibody, Factor V Leiden, Afctor VIII Level, Homocystein, Anti ß2 Glycoprotein 1 igM, Anti ß2 Glycoprotein 1 IgG : Clot Based/Chemiluminescence/Chromogenic Assay/Enzyme Immunoassay/PCR Sequencing

Thrombocheck DNA Afctor V Mutation MTHFR Gene Mutation FactorII (Prothrombin) Mutation : PCR Sequencing

Thrombotic Risk Profile Automated D-Dimer, Prothrombin Time, APTT, Fibrinogen : Immunoturbidometry/Clot Based/Claus Clotting Method

Thrombochek Acquired Panel Lupus Anticoagulant, Anti ß2 Glycoprotien 1 IgG, Anti ß2 Glycoprotein 1 IgM : Clot Based, Enzyme Immuno Assay

Automated D-Dimer Panel (D-Dimer, CRP) : Immunoturbidometry, Latex Particle Agglutination (LPA)

Thrombocheck Advanced Protein C Activity, Free Protein S Antigen Levels, Anti Thrombin Activity (Chromo-Genic), Lupus Anticoagulant (Both APTT and RVVT Based), Anti Cardiolipin Antibody, Factor V Leiden, Factor VIII Level, Homocystein, Anti ß2 Glycoprotein 1 IgM, Anti ß2 Glycoprotien 1 IgG, Jak2 Mutation : Clot Based/Chemiluminescence/Chromogenic Assay/Enzyme Immunoassay/PCR Sequencing

Cysticercus (Taenia Solium Igg, Csf (CSF, EIA) : EIA

Cysticercus (Taenia Solium Igg, Csf (Serum,EIA) : EIA

HOLOTC- Holo Transcobalamine (Active Vit-b 12 Deficiency) : Chemiluminescent Microparticle Immunoassay (CMIA)

Serum ceruloplasmin : Nephelometry

Serum Copper : ICPMS

Random Urine Copper : ICPMS

Heavy Metal Screen : AAS, ICPMS

Neuroviruses Comprehensive Panel : RTPCR

ANA (IF)

Total IgG Level

P-ANCA Level

S. Copper

S. Cesulophasmin

24 hr Urinary copper

Fecal Celproctectin

IL-6 Level

TNF-L Level

Fecal Elastase

S. IgG₄ Level

TPMT Assay

HBCAg

Anti UBCAb

IgM/Anti HSV-I

IgM/Anti HSV-II

S.ACE Level

IgG Anti HSV-I

IgG Anti HSV-II

Urinary Porphobilinogen

Double Marker : beta-human chorionic gonadotropin (beta-hCG) and pregnancy-associated plasma protein A (PAPP-A0 levels

Quadruple Marker : Alpha-fetoprotein, human chorionic gonadotropin, estriol, and inhibin A levels

Hb electrophoresis : The test uses the principles of gel electrophoresis to separate out the various types of hemoglobin and is a type of native gel electrophoresis

APLA profile (Anti-cardiolipin IgG and/or IgM, Anti-ß2 glycoprotein I IgG and/or IgM, Lupus anticoagulant) : Anti-cardiolipin IgG and/or IgM measured by standardized, non-cofactor dependent ELISA, Anti-ß2 glycoprotein I IgG and/or igM measured by standardized ELISA

HPV Test : HPV can be detected through tests that identify high risk HPV types, either by amplification of a viral DNA fragment (with or without genotyping), or through mRNA detection HPV DNA tests identify the DNA of one or more oncogenic HPV types without prior DNA amplification. Other detection tests amplify a viral DNA fragment using polymerase chain reaction (PCR) to obtain copies, both conventionally and in real-time. HPV genotyping identifies specific viral types (usually HPV 16 and 18). The mRNA tests identify expression of HPV E6 and E7 oncoproteins

Human Karyotyping (parental/fetal/product of conceptus) : A karyotype is the general appearance of the complete set of chromosomes in the cells of a species or in an individual organism, mainly including their sizes, numbers, and shapes. The study of karyotypes is made possible by staining. Usually a suitable dye, such as Giemsa, is applied after cells have been arrested during cell division by a solution of colchicine usually in metaphase or prometaphase when most condensed. In order for the Giemsa stain to adhere correctly, all chromosomal proteins must be digested and removed. For humans, white blood cells are used most frequently because they are easily induced to divide and grow in tissue culture.

Estradiol (E2) : The Estradiol ELISA kit is intended for the quantitative determination of Estradiol (E2) concentration in human serum and plasma.

Progesterone (P4) : The Progesterone ELISA kit is used for the quantitative measurement of Progesterone in human serum or plasma

APLA Profile

Autoimmune Hepatitis Panel

Fecal calprotectin

Serum free light chain assay

Urine AFB

TB feron

BCR ABL

Measured Serum Osmolality

Measured Urine Osmolality

Blood ketone bodies

Serum bicarbonate

Serum and urine toxin panel

Quantitative blood culture

Serum cerulopasmin

C difficle GDH, Toxin testing

Autoimmune markers: Antinuclear antibody, anti smooth muscle antibody, anti liver kidney micrsomal antibodies, Immunoglobulin G Level

Serum valproate, Phenytoin, Carbamazipine

CSF viral screen

Autoimmune encephalitis, autoimmune hepatitis panels

24 hours urinary copper

Serum fibrinogen

Biofire panels

Serum and BAL galactomannan, Mannan-antimannan antibody, Beta D Glucan

Flow cytometry

Flow cytometry (from 2.62 to 2.73): Acute Leukemia Panel

Chronic Leukemia Panel

Acute Leukemia Prognostic Disease Panel

Acute Myeloid Leukemia Panel

Acute Lymphoblastic Leukemia Panel

Minimal Residual Disease (MRD) Analysis

Flow crossmatch

HLA B27 Detection by FCM

IgG Heavy Chain

LGL Panel

Lymphocyte Subset Enumeration CD3,CD4, ,CD8,CD19

Lymphocyte Subset Enumeration, Basic

Pathkind Diagnostics Private limited

M/S Alliance Health Centre

Core Diagnostics Private limited

Bidder Name

Core Diagnostics Private limited

Pathkind Diagnostics Private limited

M/S Alliance Health Centre

Core Diagnostics Private limited